Bioatla, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
BCAB
Bioatla, INCSCHEDULE: OPOKA Fund Reduces BioAtla Stake to 4.8%
OPOKA Investment Fund Co has reduced its beneficial ownership in BioAtla, Inc. to 4.8% of common stock, indicating a passive investment stance.
NASDAQ
BCAB
Bioatla, INCSCHEDULE 13G/A: Acorn Bioventures and Affiliates Disclose Significant Passive Stake in BioAtla, Inc.
Acorn Bioventures, L.P., Acorn Bioventures 2, L.P., and their affiliates, including Anders Hove, have disclosed a combined beneficial ownership of 8.3% of BioAtla, Inc.'s common stock as a passive investment.
NASDAQ
BCAB
Bioatla, INCHighbridge Capital Management, LLC has filed an amended Schedule 13G, disclosing a 7.7% beneficial ownership stake in BioAtla, Inc., primarily through warrants.
NASDAQ
BCAB
Bioatla, INCOpoka Investment Fund Co. has disclosed a 6.1% passive ownership stake in BioAtla, Inc., holding 3,547,787 common shares.
NASDAQ
BCAB
Bioatla, INCHighbridge Capital Management, LLC has reported a 9.9% beneficial ownership stake in BioAtla, Inc., including shares issuable upon warrant exercise, as of December 31, 2024.
NASDAQ
BCAB
Bioatla, INCSCHEDULE 13G/A: BioAtla Co-founder Jay M. Short Updates Significant Stake, Reports 6.6% Beneficial Ownership
BioAtla, Inc.'s Co-founder, Chairman, and CEO, Jay M. Short, has filed an amended Schedule 13G, disclosing a beneficial ownership of 6.6% of the company's common stock as of December 31, 2024.
NASDAQ
BCAB
Bioatla, INCMillennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed an amended Schedule 13G, reporting a passive beneficial ownership of 1.9% in BioAtla, Inc.'s common stock as of December 31, 2024.